Evaluating the Utility of CEREBO - A machine learning powered near-Infrared Spectroscopy based device, in reducing the mean transfer time from injury to treatment in patients with traumatic brain injury

Comprehensive Assessment of CEREBO to evaluate its clinical performance, utility and Usability in the Brain Injury Management - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070704

Enrollment

134

Registered

2024-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S068- Other specified intracranial injuries

Interventions

Intervention1: NIR based device - CEREBO: The experimental group will consist of head injury patients who are recommended for head CT/MRI scans. The participants will undergo a one-time scan with the

Eligibility

Inclusion criteria

Inclusion criteria: Patients with head injury referred for head CT/MRI scan

Exclusion criteria

Exclusion criteria: Patients with scalp bruises or hematoma.

Design outcomes

Primary

Measure	Time frame
Assessing the utility of CEREBO in reducing the mean transfer time from injury to treatmentTimepoint: 3 years	—

Secondary

Measure	Time frame
To assess the usability among healthcare professionals & operators & identify areas of improvement for specific use casesTimepoint: 3 years	—

Countries

India

Contacts

Public ContactDr Zahir Quazi

Datta Meghe Institute of Higher Education & Research

zahirquazi@gmail.com9765404065

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026